Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Trichophyton mentagrophytes genotype VII is a sexually transmitted fungus causing skin issues, mainly among men who have sex with men in Europe, and requires quick treatment.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Finasteride can cause long-lasting sexual dysfunction even after stopping the drug.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

PCOS causes sexual dysfunction, needing comprehensive treatment.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Both finasteride and dutasteride can cause sexual side effects, but they may differ in frequency and severity.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Low-dose finasteride may increase erectile dysfunction risk over time.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Finasteride can cause depression, suicidal thoughts, and lasting psychiatric and sexual issues.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.